Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025Current Signal Transduction Therapy

Computational Evaluation of ADMET Properties and Molecular Docking Studies of 1,2,4-oxadiazole Analogs as Potential Inhibitors of Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

SSwatiSKShubham KumarPWPankaj Wadhwa

Discussion

Loading...

Member takes

Overview

Computational analysis identifies novel 1,2,4-oxadiazole derivatives with optimized ADMET properties, suggesting enhanced efficacy over current therapies.

Key Points

  • Molecular docking identified 10 potential inhibitors for prostate cancer with significant binding affinities and safety profiles.
  • The generated 1,2,4-oxadiazole derivatives exhibited favorable ADMET properties, including high gastrointestinal absorption and low toxicity.
  • These compounds represent promising candidates for improving the therapeutic options available for prostate cancer.
  • The findings emphasize the potential of next-generation non-steroidal anti-androgens for safer cancer treatment alternatives.

Cite This Study

Swati et al. (2025) studied this question.

synapsesocial.com/papers/68d42321713b0b5dfea6ab47https://doi.org/10.2174/0115743624372168250819040901
View Full Paper
Ask AI
Bookmark
Share